Three Treatments for EGFR-Mutant Non-Small-Cell Lung Cancer with Brain Metastases

被引：0
作者：
Fan, Y. [1 ]
Yu, X. [2 ]
Wang, H. [2 ]
机构：
[1] Zhejiang Canc Hosp, Chemotherapy, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Canc Hosp, Thorac Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Epidermal growth factor receptor; Tyrosine kinase inhibitors; brain metastases;
D O I：
10.1016/j.jtho.2017.09.1510
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-069
引用
收藏
页码：S2228 / S2228
页数：1
相关论文
共 50 条
  • [21] EGFR-Mutant Non-Small-Cell Lung Cancer at Surgical Stages: What Is the Place for Tyrosine Kinase Inhibitors?
    Cansouline, Xavier
    Lipan, Beatrice
    Sizaret, Damien
    Tallet, Anne
    Vandier, Christophe
    Carmier, Delphine
    Legras, Antoine
    [J]. CANCERS, 2022, 14 (09)
  • [22] The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer
    Bai, Hao
    Xiong, Liwen
    Han, Baohui
    [J]. ONCOTARGETS AND THERAPY, 2017, 10 : 2335 - 2340
  • [23] Non-Small-Cell Lung Cancer and Brain Metastases in Brazil
    Weis, Luiza N.
    Coelho, Juliano C.
    Marks, Patricia
    Geib, Guilherme
    Liedke, Pedro
    Pereira, Rodrigo
    Schwartsmann, Gilberto
    Azevedo, Sergio
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : S204 - S205
  • [24] Management of EGFR-Mutant Non-Small Cell Lung Cancer: Focus on Gefitinib
    Naito, Yoichi
    Goto, Koichi
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1027 - 1040
  • [25] The Effectiveness of Afatinib as First-Line Treatment in Vietnamese Patients With EGFR-Mutant Non-Small Cell Lung Cancer and Brain Metastases
    Van Pham, Thai
    Vu, Thanh Ha
    Nguyen, Hoa Thai Thi
    Pham, Phuong Cam
    Do, Anh Tu
    Nguyen, Tuan Khoi
    Hoang, Thi Anh Thu
    Le, Tuan Anh
    Vuong, Dinh Thy Hao
    Nguyen, Dac Nhan Tam
    Dang, Van Khiem
    Nguyen, Thi Oanh
    Pham, Van Luan
    Nguyen, Minh Hai
    Vo, Thi Huyen Trang
    Mai, Khoa Trong
    Do, Hung Kien
    Nguyen, Thi Thuy Hang
    Trinh, Le Huy
    Nguyen, Hoang Gia
    Truong, Cong Minh
    Pham, Tran Minh Chau
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, : 281 - 289
  • [26] Continuation of osimertinib in EGFR-mutant non-small-cell lung cancer patients bearing CNS metastasis (EPONA study)
    Okuma, Yusuke
    Nomura, Shogo
    Ninomiya, Kiichiro
    Gyotoku, Hiroshi
    Murakami, Shuji
    Kogure, Yoshihito
    Harada, Daijiro
    Okishio, Kyoichi
    Okamoto, Hiroaki
    Goto, Yasushi
    [J]. FUTURE ONCOLOGY, 2023, : 1515 - 1521
  • [27] Prognostic impact of pleural effusion in EGFR-mutant non-small cell lung cancer patients without brain metastasis
    Yoshimura, Akihiro
    Yamada, Tadaaki
    Tsuji, Taisuke
    Hamashima, Ryosuke
    Shiotsu, Shinsuke
    Yuba, Tatsuya
    Takumi, Chieko
    Uchino, Junji
    Hiraoka, Noriya
    Takayama, Koichi
    [J]. THORACIC CANCER, 2019, 10 (03) : 557 - 563
  • [28] EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data
    Fan, Yun
    Xu, Xiaoling
    Xie, Conghua
    [J]. ONCOTARGETS AND THERAPY, 2014, 7 : 2075 - 2084
  • [29] Effects of EGFR-TKIs combined with intracranial radiotherapy in EGFR-mutant non-small cell lung cancer patients with brain metastases: a retrospective multi-institutional analysis
    He, Mingfeng
    Wu, Xue
    Li, Li
    Yi, Guangming
    Wang, Yitian
    He, Hengqiu
    Ye, Ying
    Zhou, Ruiqin
    Xu, Zaicheng
    Yang, Zhenzhou
    [J]. RADIATION ONCOLOGY, 2025, 20 (01)
  • [30] Targeted Therapy for Brain Metastases in EGFR-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer
    Baik, Christina S.
    Chamberlain, Marc C.
    Chow, Laura Q.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : 1268 - 1278
12345